Kindstar Globalgene Technology (HKSE:09960) Days Payable : 136.67 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Days Payable?

Kindstar Globalgene Technology's average Accounts Payable for the six months ended in Dec. 2024 was HK$192.3 Mil. Kindstar Globalgene Technology's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$256.7 Mil. Hence, Kindstar Globalgene Technology's Days Payable for the six months ended in Dec. 2024 was 136.67.

The historical rank and industry rank for Kindstar Globalgene Technology's Days Payable or its related term are showing as below:

HKSE:09960' s Days Payable Range Over the Past 10 Years
Min: 102.58 Med: 107.64 Max: 186.53
Current: 145.81

During the past 7 years, Kindstar Globalgene Technology's highest Days Payable was 186.53. The lowest was 102.58. And the median was 107.64.

HKSE:09960's Days Payable is ranked better than
71.07% of 197 companies
in the Medical Diagnostics & Research industry
Industry Median: 60.71 vs HKSE:09960: 145.81

Kindstar Globalgene Technology's Days Payable declined from Dec. 2023 (155.22) to Dec. 2024 (136.67). It may suggest that Kindstar Globalgene Technology accelerated paying its suppliers.

Kindstar Globalgene Technology Days Payable Historical Data

The historical data trend for Kindstar Globalgene Technology's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Days Payable Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

102.58

107.64

104.19

186.53

151.53

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial							115.75	197.55	155.22	149.63	136.67

Competitive Comparison of Kindstar Globalgene Technology's Days Payable

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindstar Globalgene Technology's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Days Payable distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Days Payable falls into.

Save Embed

;

Save Embed

;

Kindstar Globalgene Technology Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Kindstar Globalgene Technology's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (242.535	+	190.065)	/	2 )	/	521.029	*	365
=	216.3					/	521.029	*	365
=	151.53

Kindstar Globalgene Technology's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (194.461	+	190.065)	/	2 )	/	256.733	*	365 / 2
=	192.263					/	256.733	*	365 / 2
=	136.67

Kindstar Globalgene Technology Days Payable Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.

Executives

Orbimed Asia Partners Iv, L.p.	2101 Beneficial owner
Orbimed Asia Gp Iv, L.p.	2201 Interest of corporation controlled by you
Orbimed Advisors Iv Limited	2201 Interest of corporation controlled by you
Cpe Holdings International Limited	2201 Interest of corporation controlled by you
Cpechina Fund Iii, L.p.	2201 Interest of corporation controlled by you
Cpe Holdings Limited	2201 Interest of corporation controlled by you
Cpe Funds Iii Limited	2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited	2101 Beneficial owner
Jackson Hole Trust Company
Huang Bo
Huang Shiang	2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Huang Zuie-chin	2101 Beneficial owner
Tu Zanbing
Kastle Limited	2301 Trustee

Kindstar Globalgene Technology Headlines

No Headlines